Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119226602 | 11922660 | 2 | F | 20140516 | 20160922 | 20160115 | 20160923 | PER | US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-01447BI | BOEHRINGER INGELHEIM | 68.87 | YR | F | Y | 0.00000 | 20160923 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119226602 | 11922660 | 1 | PS | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | Oral | 300 MG | 22512 | 150 | MG | CAPSULE | BID | ||||||
| 119226602 | 11922660 | 2 | C | ASPIRIN. | ASPIRIN | 1 | Oral | FORMULATION: PACKET; DAILY DOSE: 1 PACKET DAILY AS NEEDED | 0 | QD | |||||||||
| 119226602 | 11922660 | 3 | C | CITRACAL + D | CALCIUM CITRATEVITAMIN D | 1 | Oral | DOSE PER APPLICATION: 315-200 MG; DAILY DOSE: 2 TABLETS EVERY MORNING AND 1 TABLET IN THE EVENING | 0 | TABLET | BID | ||||||||
| 119226602 | 11922660 | 4 | C | TAMBOCOR | FLECAINIDE ACETATE | 1 | Oral | 100 MG | 0 | 50 | MG | TABLET | Q12H | ||||||
| 119226602 | 11922660 | 5 | C | CLARITIN | LORATADINE | 1 | Oral | 10 MG | 0 | 10 | MG | TABLET | QD | ||||||
| 119226602 | 11922660 | 6 | C | DILTIAZEM. | DILTIAZEM | 1 | Oral | 240 MG | 0 | 240 | MG | CAPSULE | QD | ||||||
| 119226602 | 11922660 | 7 | C | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | 20 MG | 0 | 20 | MG | CAPSULE | QD | ||||||
| 119226602 | 11922660 | 8 | C | REQUIP | ROPINIROLE HYDROCHLORIDE | 1 | Oral | 2 MG | 0 | 2 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119226602 | 11922660 | 1 | Atrial fibrillation |
| 119226602 | 11922660 | 2 | Product used for unknown indication |
| 119226602 | 11922660 | 3 | Product used for unknown indication |
| 119226602 | 11922660 | 4 | Product used for unknown indication |
| 119226602 | 11922660 | 5 | Product used for unknown indication |
| 119226602 | 11922660 | 6 | Product used for unknown indication |
| 119226602 | 11922660 | 7 | Product used for unknown indication |
| 119226602 | 11922660 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119226602 | 11922660 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119226602 | 11922660 | Haemorrhagic anaemia | |
| 119226602 | 11922660 | Lower gastrointestinal haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119226602 | 11922660 | 1 | 20140409 | 20140529 | 0 |